- Sienna Biopharmaceuticals $40,000,000
Round: Series B
Industry: Biotechnology, Medical, Pharmaceutical
Date announced: 4/24
Investors in the round: Lead – ARCH Venture Partners, Lead – Venvest Capital, David Pyott, Partner Fund Management, Altitude Life Science Ventures
Page 11 of 11